|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,407.00 JPY | -0.61% |
|
-3.29% | +14.12% |
| 02-24 | Sarepta Therapeutics, Inc. Announces Commercial Launch of ELEVIDYS in Japan | CI |
| 02-24 | Sarepta Therapeutics Says Elevidys Available in Japan for Duchenne Muscular Dystrophy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD. | Other Pharmaceuticals | -0.61% | -3.29% | +14.12% | +35.59% | +108.26% | 98.08B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4519 Stock
- Charts Chugai Pharmaceutical Co., Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition